Journal of Materials Chemistry B · 2017 · 38 citations · 44 references
Natural SciencesMedicinal ChemistryPharmacologyBiophotonicsMolecular ImagingTheranosticsFluorescence ImagingFluorescence SpectroscopyPhotochemistryPhotodynamic TherapyPhotophysics Of Fluorescent ProbesTargeted Imaging AgentsCancer Photodynamic TherapyHeavy Atom EffectIntramolecular Electron TransferPhotosensitizersPhotosensitizing CompoundsPhototoxicityPhototoxicity In Fluorescence ImagingPhototoxicity Reduction
The currently available photodynamic sensitizers usually lead to undesirable side effects, including dark toxicity from heavy-atom effect and nonspecific phototoxicity. To address these issues, we designed and prepared a smart photosensitizer from boron dipyrromethene (BODIPY), and the dark toxicity and phototoxicity were reduced via heavy-atom-free substitution and controllable photosensitization, respectively. Importantly, the photodynamic effect together with fluorescence imaging can be simultaneously switched on through the suppression of intramolecular charge transfer (ICT) and photoinduced electron-transfer (PeT) induced by cancer-related biothiol glutathione (GSH) in a buffer solution. Moreover, the sensitizer exhibits obvious fluorescence enhancement and selective phototoxicity towards cancer cells in a biological system upon irradiation. The present monochromatic photosensitizer, which combines fluorescence imaging and targeted PDT treatment within a single chromophore, possesses great potentials as a new activatable theranostic reagent in cancer therapy.
44
Huachao Chen, Jiangwei Tian, Weijiang He et al. · Journal of the American Chemical Society · 2015 · 806 citations
Pharmacy, Oncology, Pharmacology +17
Youyong Yuan, Chong‐Jing Zhang, Meng Gao et al. · Angewandte Chemie International Edition · 2014 · 517 citations